Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Polycystic ovary syndrome (PCOS): diagnosis and metabolic screening

Gynaecology and obstetrics · Known disease · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: 10 to 13% of women of childbearing age [1]

Suspected PCOS: diagnosis and conditions to rule out

Laboratory tests (in the morning, before 8 am for 17-hydroxyprogesterone)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Confirmed PCOS: initial cardiometabolic work-up

Fasting sample.

Fasting laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

PCOS follow-up and pregnancy planning

Fasting sample.

Every 1 to 3 years depending on risk factors

Pregnancy plan or request for assisted reproduction

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Sources (9)
  1. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al.; International PCOS Network. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-1679.
  2. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK; Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592.
  3. Nelson M, LaRouche V. Polycystic Ovary Syndrome: Assessment and Management Guidelines. Am Fam Physician. 2024;110(5):547-548.
  4. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG257, 31 mars 2026.
  5. Pugeat M, Déchaud H, Raverot V, Denuzière A, Cohen R, Boudou P; Société française d'endocrinologie. Recommendations for investigation of hyperandrogenism. Ann Endocrinol (Paris). 2010;71(1):2-7.
  6. Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(11):4043-4088.
  7. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 0793 (AMH), 1577 (HbA1c), 1802 (SDHEA).
  8. Royal College of Obstetricians and Gynaecologists. Long-term Consequences of Polycystic Ovary Syndrome (Green-top Guideline No. 33). Page du guide, archivé le 13 décembre 2024.
  9. Williams T, Moore JB, Regehr J. Polycystic Ovary Syndrome: Common Questions and Answers. Am Fam Physician. 2023;107(3):264-272.